Manages manifestations of psychotic disorders. ANDA 83386, held by Upsher Smith Labs. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 83386 (Chlorpromazine Hydrochloride), held by Upsher Smith Labs, was first approved by FDA on Jul 9, 1974, with 28 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the treatment of tetanus. To control the manifestations of the manic type of manic-depressive illness. For relief of intractable hiccups.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 9, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride10MG · tablet;oral | Chlorpromazine Hydrochloride | RxReference drug |
| Feb 5, 2020 | Supplement 98Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 95Labeling · Standard review | Approved | None posted |
| Aug 29, 2016 | Supplement 94Labeling · Standard review | Approved | None posted |
| Sep 13, 2011 | Supplement 90Labeling | Approved | None posted |
| Dec 3, 2010 | Supplement 87Labeling | Approved | None posted |
| Aug 18, 2009 | Supplement 84Labeling | Approved | None posted |
| Nov 19, 2008 | Supplement 81Labeling | Approved | None posted |
| Nov 25, 2002 | Supplement 66Labeling | Approved | None posted |
| Mar 22, 1999 | Supplement 65Labeling | Approved | None posted |
| Mar 22, 1999 | Supplement 64Manufacturing | Approved | None posted |
| Feb 5, 1996 | Supplement 63Manufacturing | Approved | None posted |
| Sep 16, 1992 | Supplement 62Labeling | Approved | None posted |
| Dec 31, 1991 | Supplement 61Labeling | Approved | None posted |
| Nov 29, 1990 | Supplement 60Labeling | Approved | None posted |
| Apr 14, 1989 | Supplement 59Manufacturing | Approved | None posted |
| Oct 24, 1988 | Supplement 58Manufacturing | Approved | None posted |
| Apr 26, 1988 | Supplement 57Labeling | Approved | None posted |
| Apr 14, 1988 | Supplement 54Manufacturing | Approved | None posted |
| Mar 8, 1988 | Supplement 55Labeling | Approved | None posted |
| Dec 8, 1987 | Supplement 53Manufacturing | Approved | None posted |
| Dec 8, 1987 | Supplement 51Manufacturing | Approved | None posted |
| Dec 8, 1987 | Supplement 50Manufacturing | Approved | None posted |
| Jul 10, 1986 | Supplement 49Manufacturing | Approved | None posted |
| Jul 10, 1986 | Supplement 48Manufacturing | Approved | None posted |
| Mar 10, 1986 | Supplement 46Manufacturing | Approved | None posted |
| Nov 26, 1984 | Supplement 45Manufacturing | Approved | None posted |
| Nov 26, 1984 | Supplement 44Manufacturing | Approved | None posted |
| Nov 26, 1984 | Supplement 43Manufacturing | Approved | None posted |
| Jul 9, 1974 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters